PGP and cancer: Pluronic® L61 was shown to sensitize DOX-resistant cancer cells through an interplay between ATP depletion, membrane fluidization, and inhibition of P-gp ATPase activity, while Pluronic® F127 provided micellar stabilization [156,157].